John Bencich
CEO at Achieve Life Sciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Achieve Life Sciences Inc., 3 years.
Achieve Life Sciences Inc.
Director · CEO
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 2024 | Achieve Life Sciences Inc. | Grant or award | +5,000 | $3.67 | $18,350 |
| Apr 19, 2024 | Achieve Life Sciences Inc. | Option exercise | +25,000 | — | — |
| Apr 19, 2024 | Achieve Life Sciences Inc. | Shares withheld for tax | −6,088 | $4.51 | $27,457 |
| Mar 4, 2024 | Achieve Life Sciences Inc. | Open-market purchase | +10,000 | $4.59 | $45,900 |
| May 30, 2023 | Achieve Life Sciences Inc. | Open-market purchase | +5,000 | $5.50 | $27,500 |
| Apr 28, 2023 | Achieve Life Sciences Inc. | Option exercise | +7,500 | — | — |
| Apr 28, 2023 | Achieve Life Sciences Inc. | Shares withheld for tax | −1,827 | $8.29 | $15,146 |
| Apr 21, 2023 | Achieve Life Sciences Inc. | Option exercise | +25,000 | — | — |
| Apr 21, 2023 | Achieve Life Sciences Inc. | Shares withheld for tax | −7,324 | $6.80 | $49,803 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.